VanEck Pharmaceutical ETF
PPH NASDAQ
VanEck Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including phar...
Hover to inspectDrag to measure a move← → to step through days
- Fund size
- 171M as of Feb 2020
- Expense ratio
- 0.35% per year
- Dividend yield
- 1.93% Quarterly
- Volatility · 1Y
- 17.9% Average Risk
- Beta
- 0.39 vs the market
- 52-week range
- 89.16117.48
How PPH has paid off
Price return over every period, and total return with dividends reinvested, set against its benchmark.
Return by period
Price · to Oct 12Total return vs benchmark
Total Market US Cap Weighted 1200 IndexOver 1 year, PPH returned +25.3% with dividends reinvested — −28.4 pts behind its benchmark.
How bumpy is the ride?
Return only means something next to the risk taken to earn it. Volatility, drawdowns and market sensitivity over 1 year.
Volatility
Annualized · 1YA typical year sees the price swing about ±18% around its trend.
Drawdown from peak
How far below its previous high the price has been Deepest fall −10.8% on Apr 29, 2026 — 61 days after the previous high
More than 5% below a high 36% of the time.
Risk vs reward
1YOver 1 year, PPH delivered less return with more risk than its benchmark.
Market sensitivity
BetaA beta of 0.39 means PPH has moved less than the market.
Trend & momentum
Where the price sits against its moving averages, and how stretched the recent move is.
Price vs moving averages
Uptrend- 12-day average109.71 +0.9%
- 26-day average110.24 +0.4%
- 50-day average110.32 +0.3%
- 200-day average105.38 +5.0%
The price is above 4 of 4 averages. The 50-day average is above the 200-day, a sign of a rising longer-term trend.
Relative strength (RSI)
NeutralRSI compares recent gains with recent losses on a 0–100 scale. Above 70 a move is often considered stretched, below 30 washed out.
Technical indicators describe past prices. They are not a forecast.
Inside the fund
Health Care · Pharma — tracking the MVIS® US Listed Pharmaceutical 25 Index.
- Assets under management171MUSD
- Expense ratio0.35%per year
- Holdings26
- Risk score4.9Medium
Launched December 2011. Listed options available. Fund data as of Feb 28, 2020.
What it pays you
Cash distributions over the last twelve months, and how they have grown.
About 19 USD a year for every 1,000 USD invested at today's price.
- Per share
- 2.14
- Frequency
- Quarterly
- Last paid
- Oct 1, 2026
Last 12 months
2.14 USD / shareWhere PPH shows up
Curated themes and indices that hold PPH. Open one to see it in context, or test the whole theme in a portfolio.
About VanEck Pharmaceutical ETF
VanEck Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
- Featured in 1 curated theme
- 26 holdings
- Ticker
- PPH
- Exchange
- NASDAQ
- ISIN
- US92189F6925
- CUSIP
- 92189F692
- Currency
- U.S. Dollar (USD)
- Country
- USA
- Sector
- Health Care
- Industry
- Pharma
- Benchmark
- Total Market US Cap Weighted 1200 Index
All key statistics
Details
Shareas of Oct 12, 2026
Dataas of Feb 28, 2020
Put PPH to the test
See how it would change the return and the risk of a portfolio, with virtual money, before a single real dollar moves.
Data for information only, not investment advice. Past performance does not guarantee future results.